How Do Clinicians Adjust Lamotrigine Doses and Use Lamotrigine Blood Levels?-A Q-PULSE Survey.
作者信息
Privitera Michael, Welty Timothy, Gidal Barry, Carlson Chad, Pollard John, Berg Michel
机构信息
Professor of Neurology, Director of Epilepsy Center, University of Cincinnati Neuroscience Institute, Cincinnati, OH.
Professor and Chair, Department of Clinical Sciences, College of Pharmacy and Health Sciences, Drake University, Des Moines, IA.
出版信息
Epilepsy Curr. 2014 Jul;14(4):218-23. doi: 10.5698/1535-7597-14.4.218.
Abstract
摘要
相似文献
1
How Do Clinicians Adjust Lamotrigine Doses and Use Lamotrigine Blood Levels?-A Q-PULSE Survey.
Epilepsy Curr. 2014 Jul;14(4):218-23. doi: 10.5698/1535-7597-14.4.218.
2
Are doses of lamotrigine or levetiracetam adjusted during pregnancy?
Epilepsia Open. 2017 Nov 27;3(1):86-90. doi: 10.1002/epi4.12086. eCollection 2018 Mar.
3
Lamotrigine in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid, and cord blood.
Int Clin Psychopharmacol. 2015 Sep;30(5):249-54. doi: 10.1097/YIC.0000000000000088.
4
Variation in dose and plasma level of lamotrigine in patients discharged from a mental health trust.
Ther Adv Psychopharmacol. 2017 Jan;7(1):17-24. doi: 10.1177/2045125316672573. Epub 2016 Oct 13.
5
Therapeutic drug monitoring of lamotrigine.
Ann Pharmacother. 2002 May;36(5):917-20. doi: 10.1345/aph.1A252.
6
Treatment of epilepsy in adults: expert opinion, 2005.
Epilepsy Behav. 2005 Sep;7 Suppl 1:S1-64; quiz S65-7. doi: 10.1016/j.yebeh.2005.06.001.
7
Phenobarbital/Lamotrigine coadministration-induced blood dyscrasia in a patient with epilepsy.
Ann Pharmacother. 2010 Dec;44(12):2031-4. doi: 10.1345/aph.1P335. Epub 2010 Nov 23.
8
The effects of lamotrigine on the acquisition and expression of morphine-induced place preference in mice.
Pak J Biol Sci. 2009 Jan 1;12(1):33-9. doi: 10.3923/pjbs.2009.33.39.
9
The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probe.
Clin Pharmacol Ther. 2008 Dec;84(6):698-703. doi: 10.1038/clpt.2008.106. Epub 2008 Jun 4.
10
Remedial dosing recommendations for delayed or missed doses of lamotrigine in pediatric patients with epilepsy using Monte Carlo simulations.
Epilepsy Behav. 2019 Jul;96:132-140. doi: 10.1016/j.yebeh.2019.04.007. Epub 2019 May 24.
引用本文的文献
1
Risk-Based Bioequivalence Recommendations for Antiepileptic Drugs.
Curr Neurol Neurosci Rep. 2017 Sep 19;17(11):82. doi: 10.1007/s11910-017-0795-1.
本文引用的文献
1
Taking the "Pulse" of Our Society with Q-PULSE.
Epilepsy Curr. 2013 Nov;13(6):304. doi: 10.5698/1535-7597-13.6.304.
2
Generic substitution of antiepileptic drugs: What's a clinician to do?
Neurol Clin Pract. 2013 Apr;3(2):161-164. doi: 10.1212/CPJ.0b013e31828d9fc9.
3
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration.
AAPS J. 2012 Dec;14(4):915-24. doi: 10.1208/s12248-012-9406-x. Epub 2012 Sep 13.
4
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
Ann Pharmacother. 2009 Oct;43(10):1583-97. doi: 10.1345/aph.1M141. Epub 2009 Sep 23.
5
Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy.
Neurology. 2007 Apr 17;68(16):1249-50. doi: 10.1212/01.wnl.0000259400.30539.cc.
Zotero 插件